Achieve a high-level sterile environment for cell preparation with space-saving design and low running costs!
The "Closed Safety Cabinet - CSC Series" achieves a high-level sterile environment for cell preparation with space-saving design and low running costs, and it can handle cells and tissues from multiple donors by adopting a detachable cell culture CO2 incubator. Equipped with a hydrogen peroxide vapor generator, it allows for validated high-level decontamination during changeover. The cell culture CO2 incubator is detachable, enabling support for cells and tissues from multiple donors by adding more units. The cell culture CO2 incubator and centrifuge unit dock together, allowing the main processes of cell preparation to be carried out in a sterile environment. This eliminates the need for a large cleanroom, significantly reducing both initial and running costs. 【Features】 ■ Eliminates the need for expensive sterile clothing, greatly reducing the burden on operators along with running costs. ■ Equipped with a window for an LCD monitor, allowing projection of observation images from commercially available microscopes. ■ Equipped with a decontamination pass box, allowing the exterior of reagents and instruments brought into the work area to be decontaminated with hydrogen peroxide vapor. ■ Ensures reliable decontamination through CT control. *For more details, please download the PDF or contact us.
Inquire About This Product
basic information
■CSC-18PS Specifications Product Name/Model Number: Closed Safety Cabinet CSC-18PS External Dimensions: Main Body W2,710 D1,090 H2,080mm Electrical Box W900 D300 H1,970mm Power Supply: Single-phase AC200V 50/60Hz
Price range
Delivery Time
Applications/Examples of results
Manufacturing and preparation of regenerative medicine/cell therapy.
catalog(1)
Download All CatalogsCompany information
BioMedica Solutions Co., Ltd. is a company formed through collaboration between Panasonic Healthcare Co., Ltd. (formerly Sanyo Electric Co., Ltd. BioMedica Division), a top manufacturer of cell culture processing facilities and equipment, and Terra Co., Ltd., which possesses cell culture technology, know-how, and the largest track record of human cell culture in Japan. We aim to provide the latest cell culture technology and management know-how, contributing to the realization of regenerative medicine and cell therapy, and striving for a society where many people can safely receive cell therapy.